8-Cl-cAMP and its metabolite, 8-Cl-adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways: Protein kinase C activation and cyclin B down-regulation

Journal of Cellular Physiology

Volumn 201, Issue 2, 2004, Pages 277-285

  Ahn, Young Ho ^a   Jung, Joong Mok ^a   Hong, Seung Hwan ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; ADENOSINE DEAMINASE; ADENOSINE KINASE INHIBITOR; CYCLIN B; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE C; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVATION; FIBROBLAST; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER;

2-CHLOROADENOSINE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CYCLIN B; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLASTS; MICE; NIH 3T3 CELLS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 4644330049     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20047     Document Type: Article

References (38)

1. Beebe SJ, Segaloff DL, Burks D, Beasley-Leach A, Limbird LE, Corbin JD. 1989. Evidence that cyclic adenosine 3′,5′-monophosphate-dependent protein kinase activation causes pig ovarian granulosa cell differentiation, including increases in two type II subclasses of this kinase. Biol Reprod 41:295-307.
2. Black JD. 2000. Protein kinase C-mediated regulation of the cell cycle. Front Biosci 5:D406-D423.
3. Boulogne B, Habert R, Levacher C. 2003. Regulation of the proliferation of cocultured gonocytes and sertoli cells by retinoids, triiodothyronine, and intracellular signaling factors: Differences between fetal and neonatal cells. Mol Reprod Dev 65:194-203.
4. Cambier JC, Newell MK, Justement LB, McGuire JC, Leach KL, Chen ZZ. 1987. Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature 327:629-632.
5. Chen J, Iyengar R. 1994. Suppression of Ras-induced transformation of NIH 3T3 cells by activated G alpha s. Science 263:1278-1281.
6. Cho-Chung YS. 1992. Modulation of adenylate cyclase signalling. Semin Cancer Biol 3:361-367.
7. Cho-Chung YS, Clair T, Tagliaferri P, Ally S, Katsaros D, Tortora G, Neckers L, Avery TL, Crabtree GW, Robins RK. 1989. Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest 7:161-177.
8. Cummings J, Fielding H, Miller WR. 1994. Pharmaceutical analysis of 8-chloroadenosine 3′,5′-monophosphate. J Pharm Biomed Anal 12:1289-1294.
9. Cummings J, Langdon SP, Ritchie AA, Burns DJ, Mackay J, Stockman P, Leonard RC, Miller WR. 1996. Pharmacokinetics, metabolism, and tumour disposition of 8-chloroadenosine 3′,5′-monophosphate in breast cancer patients and xenograft bearing mice. Ann Oncol 7:291-296.
10. Dekker LV, Parker PJ. 1994. Protein kinase C-A question of specificity. Trends Biochem Sci 19:73-77.
11. Dransfield DT, Griner RD, Ray S, Keskintepe M, Bollag WB. 2001. 8-Cl-adenosine induces growth arrest without differentiation of primary mouse epidermal keratinocytes. J Invest Dermatol 117:1588-1593.
12. +-channel activity by protein phosphorylation. Nature 315:503-506.
13. Gandhi V, Ayres M, Halgren RG, Krett NL, Newman RA, Rosen ST. 2001. 8-Chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res 61:5474-5479.
14. Grbovic O, Jovic V, Ruzdijic S, Pejanovic V, Rakic L, Kanazir S. 2002. 8-Cl-cAMP affects glioma cell-cycle kinetics and selectively induces apoptosis. Cancer Invest 20:972-982.
15. Halgren RG, Traynor AE, Pillay S, Zell JL, Heller KF, Krett NL, Rosen ST. 1998. 8Cl-cAMP cytotoxicity in both steroid sensitive and insensitive multiple myeloma cell lines is mediated by 8Cl-adenosine. Blood 92:2893-2898.
16. 2-dibutyryl cyclic AMP increase the rate of transcription and change the stability of lactate dehydrogenase a subunit messenger RNA in rat C6 glioma cells. J Biol Chem 258:5312-5318.
17. Kim SN, Kim SG, Park JH, Lee MA, Park SD, Cho-Chung YS, Hong SH. 2000. Dual anticancer activity of 8-Cl-cAMP: Inhibition of cell proliferation and induction of apoptotic cell death. Biochem Biophys Res Commun 273:404-410.
18. Kim SN, Ahn YH, Kim SG, Park SD, Cho-Chung YS, Hong SH. 2001. 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer 93:33-41.
19. Kraiem Z, Sadeh O, Yosef M, Aharon A. 1995. Mutual antagonistic interactions between the thyrotropin (adenosine 3′,5′-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles. Endocrinology 136:585-590.
20. Krebs EG, Beavo JA. 1979. Phosphorylation-dephosphorylation of enzymes. Annu Rev Biochem 48:923-959.
21. Kvanta A, Fredholm BB. 1993. Synergistic effects between protein kinase C and cAMP on activator protein-1 activity and differentiation of PC-12 pheochromocytoma cells. J Mol Neurosci 4:205-214.
22. Lamb D, Steinberg RA. 2002. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression. J Cell Physiol 192:216-224.
23. Langeveld CH, Jongenelen CA, Theeuwes JW, Baak JP, Heimans JJ, Stoof JC, Peters GJ. 1997. The antiproliferative effect of 8-chloroadenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics. Biochem Pharmacol 53:141-148.
24. Lee GR, Kim SN, Noguchi K, Park SD, Hong SH, Cho-Chung YS. 1999. Ala99ser mutation in RIα regulatory subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer growth. Mol Cell Biochem 195:77-86.
25. Liedtke CM, Cole TS. 1998. Antisense oligonucleotide to PKC-epsilon alters cAMP-dependent stimulation of CFTR in Calu-3 cells. Am J Physiol 275:C1357-C1364.
26. Litvin Y, PasMantier R, Fleischer N, Erlichman J. 1984. Hormonal activation of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by corticotropin releasing factor, isoproterenol, and forskolin. J Biol Chem 259:10296-10302.
27. Maurer RA. 1981. Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294:94-97.
28. Nishizuka Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
29. Parandoosh Z, Rubalcava B, Finch RA, Robins RK, Avery TL. 1990. Changes in diacylglycerol and membrane associated protein kinase C activity reflect the growth status of xenografted human mammary carcinoma treated with 8-Cl-cAMP. Cancer Lett 49:195-200.
30. Propper DJ, Saunders MP, Salisbury AJ, Long L, O'Byrne KJ, Braybrooke JP, Dowsett M, Taylor M, Talbot DC, Ganesan TS, Harris AL. 1999. Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: Toxicity, hormonal, and immunological effects. Clin Cancer Res 5:1682-1689.
31. Roberson ED, English JD, Adams JP, Selcher JC, Kondratick C, Sweatt JD. 1999. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci 19:4337-4348.
32. Sevetson BR, Kong X, Lawrence JC, Jr. 1993. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 90:10305-10309.
33. Stork PJ, Schmitt JM. 2002. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266.
34. Tortora G, Clair T, Cho-Chung YS. 1990. An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Proc Natl Acad Sci USA 87:705-708.
35. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73-82.
36. Yarwood SJ, Kilgour E, Anderson NG. 1998. Cyclic AMP potentiates growth hormone-dependent differentiation of 3T3-F442A preadipocytes: Possible involvement of the transcription factor CREB. Mol Cell Endocrinol 138:41-50.
37. Yokozaki H, Budillon A, Tortora G, Meissner S, Beaucage SL, Miki K, Cho-Chung YS. 1993. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res 53:868-872.
38. Yoshida M, Yokokura H, Hidaka H, Ikekawa T, Saijo N. 1998. Mechanism of antitumor action of PKC activator, gnidimacrin. Int J Cancer 77:243-250.